Related Experiment Videos
Neonatal thrombocytopenia and hidden maternal autoimmunity
G Tchernia1, M C Morel-Kopp, J Yvart
1Laboratoire d'Hématologie, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
British Journal of Haematology
|July 1, 1993
Summary
Severe neonatal thrombocytopenia can occur in infants born to mothers with normal platelet counts, linked to maternal autoantibodies against platelet glycoprotein Ib/IX. This suggests a mild form of maternal autoimmune thrombocytopenic purpura affecting the fetus.
Area of Science:
- Immunology
- Neonatal Medicine
- Hematology
Background:
- Investigating the cause of severe transient thrombocytopenia in newborns whose mothers had normal platelet counts.
- Ruling out common causes like maternofetal alloimmunization and other fetal thrombocytopenias.
Observation:
- 17 newborns from 11 mothers presented with severe transient thrombocytopenia.
- Mothers consistently had normal platelet counts and no prior history of platelet disorders.
- Specific autoantibodies against platelet glycoprotein Ib/IX were detected in most mothers and some neonates.
Findings:
- Maternal compensated thrombocytolysis and/or hypersplenism were identified in 10/11 mothers.
- The presence of maternal anti-platelet autoantibodies and compensated thrombocytolysis suggests mild maternal chronic autoimmune thrombocytopenic purpura (AITP) manifesting in the neonate.
- Anti-IbIX autoantibodies were also found in mothers of unaffected neonates, questioning their incidence and clinical significance.
Implications:
- This condition may represent a unique presentation of mild maternal autoimmune thrombocytopenic purpura (AITP).
- The discrepancy between maternal and fetal platelet status warrants further investigation, potentially due to conformational differences in fetal GP Ib/IX.
- Understanding the role of anti-IbIX autoantibodies is crucial for diagnosing and managing neonatal thrombocytopenia.